Correlation Between OnKure Therapeutics, and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OnKure Therapeutics, and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OnKure Therapeutics, and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OnKure Therapeutics, and Vincerx Pharma, you can compare the effects of market volatilities on OnKure Therapeutics, and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OnKure Therapeutics, with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OnKure Therapeutics, and Vincerx Pharma.

Diversification Opportunities for OnKure Therapeutics, and Vincerx Pharma

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between OnKure and Vincerx is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding OnKure Therapeutics, and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and OnKure Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OnKure Therapeutics, are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of OnKure Therapeutics, i.e., OnKure Therapeutics, and Vincerx Pharma go up and down completely randomly.

Pair Corralation between OnKure Therapeutics, and Vincerx Pharma

Given the investment horizon of 90 days OnKure Therapeutics, is expected to under-perform the Vincerx Pharma. But the stock apears to be less risky and, when comparing its historical volatility, OnKure Therapeutics, is 1.54 times less risky than Vincerx Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Vincerx Pharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  176.00  in Vincerx Pharma on September 4, 2024 and sell it today you would lose (147.00) from holding Vincerx Pharma or give up 83.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OnKure Therapeutics,  vs.  Vincerx Pharma

 Performance 
       Timeline  
OnKure Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in OnKure Therapeutics, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, OnKure Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

OnKure Therapeutics, and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OnKure Therapeutics, and Vincerx Pharma

The main advantage of trading using opposite OnKure Therapeutics, and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OnKure Therapeutics, position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind OnKure Therapeutics, and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios